This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Lucy Chard
14 Nov 2022

Lukang Pharma has launched two new products: Tulathromycin and Levodopa

Shandong Lukang Pharmaceutical Co., Ltd is a leading bio-pharmaceutical enterprise in China.

Shandong Lukang Pharma specializes in the supply of APIs, finished products and the general undertaking of CMO business. Recently, Lukang Pharma has launched two new products, Tulathromycin and Levodopa, and are working on many more. 

Established in 1966, Lukang Pharma engaged in bio-pharmaceutical business involves API, human drugs, veterinary drugs and biopesticides.

  • API such as Tylosin and Spectinomycin series are widely praised worldwide
  • Human drugs cover antibiotics, antidiabetic, antiviral drug, cardio-cerebrovascular drug, neurodegenerative drug and so on
  • Biopesticide: Bacillus Thuringiensis, Spinosad (upcoming), Gibberellin
  • Undertake CMO and CDMO business.

Why choose Lukang Pharma:

  • Sound quality management system, 56 years consistent good quality
  • Our workshops take the lead through the ISO 9001, ISO 14001, ISO 45001 system certification.
  • Strict regulatory compliance and continual improvement
  • High GMP management system such as U.S. cGMP, EU GMP and ICH Q7, as well as Chinese GMP, with all products certified by GMP
  • Complete EHS system and high-tech facilities
  • Strong production capacity, perfect equipment, advanced techniques, and complete quality supervision system
  • 2.7 square kilometers production parks, with over 6000 employees
  • API annual output: 20000+tonnes including Fermentation and Synthesis
  • Human Drug annual output: 8+billion capsules, 2+billion powder-injections, 1.5+billion tablets
  • 3 R&D centres and 5 pilot platforms throughout the country.


Lukang Pharma has more than 500 types of products, which are of human, veterinary, and agricultural use.
Our new products: Tulathromycin (GMP+DMF)/ LEVODOPA (EP/USP).
Our complete product catalogue

For more information, please contact us at [email protected] or visit our website

Mentioned Companies
View company profile
Lucy Chard
Digital Editor - Pharma

Related News